Skip to main content
Caplight Logo









NUA Surgical

NUA Surgical

Private
IrelandHealthcare & Life Scienceshttps://nuasurgical.com/

Last Round

Series A

Dec 6, 2024

Total Funding Raised

$7.66M

Company Overview

NUA Surgical is a medical device company that develops innovative surgical solutions for obstetrics and gynecology, including its flagship SteriCISION C-Section Retractor designed to improve surgical ergonomics and safety.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

surgical retractorCesarean sectionmedical deviceobstetric surgeryC-sectionsurgical instrumentationsingle-use medical devicesurgical visualizationmedtechdisposable surgical toolssurgical accesshospital equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NUA Surgical Comparables

Compare NUA Surgical with similar companies based on industry and business-model similarity.

NUA Surgical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hegenberger Medical
83%
JUNE Medical
81%
The Cooper Companies
79%

NUA Surgical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 6, 2024
GrantDec 1, 2021
GrantDec 2, 2020
GrantJun 2, 2020
AcceleratorJan 28, 2019
Grant
Oct 1, 2018

Key People

Founding team and executive leadership

Padraig Maher

Co-Founder & CTO

Founding Team

Barry Mc Cann

Founder & CEO

Founding Team

NUA Surgical Investors

Notable investors and investment history

NUA Surgical investors
InvestorRounds
InterTradeIrelandGrant
EQT Life SciencesSeries A
TechstarsAccelerator
Kidron CapitalSeries A
EIT HealthGrant
Enterprise IrelandSeries A, Grant
MATTERGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Grew 25% QoQ, from 12 to 15 employees.

  • Jul 21, 2025

    Grew 33% QoQ from 9 to 12 employees.

NUA Surgical Filings

Explore SEC and related filing metadata, where available.

NUA Surgical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NUA Surgical's valuation, stock price, and market status.

Is NUA Surgical a public or private company?

NUA Surgical is a private company.

What is the current stock price of NUA Surgical?

NUA Surgical is a private company with no public stock price. No recent secondary market data is available.

How much is NUA Surgical worth (valuation)?

Valuation information for NUA Surgical is not publicly available.

Can I buy NUA Surgical stock?

NUA Surgical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NUA Surgical's last funding round?

NUA Surgical's most recent funding round was Series A on December 6, 2024.

Who are the main investors in NUA Surgical?

Key investors in NUA Surgical include EQT Life Sciences.

Will NUA Surgical IPO soon?

No public IPO plans have been announced for NUA Surgical.

How can I track NUA Surgical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NUA Surgical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIreland
Employee Range13
Year Founded2019
Last FundingDec 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?